Furthermore, research has demonstrated that GA at concentrations up to 125 μg/mL can inhibit angiogenesis in glioma and cervical cancer cells by downregulating the signaling pathways of ADAM metallopeptidase domain 17 (ADAM17), Akt, ERK, and EGFR [196,201]. Here, ADAM17 is linked to central nervous system cancer.